本文へ

This website uses cookies for usage measurement and traffic analysis purposes.
By clicking the "Agree" button or continuing to browse this site, you consent to the use of cookies.
For more details, please refer to the Privacy Policy別ウィンドウで開く (opens in a new window).

Agree

ATLAS Asia Clinical Trials Network for Cancers Project
menu
  1. Home
  2. Member Search
  3. Yung-Yeh Su

Yung-Yeh Su , MD, PhD

Title (Affiliation)
Assistant Investigator and Attending Physician
Facility Name

National Institute of Cancer Research

Specialized Treatment Hepatobiliary and pancreatic cancer
Yung-Yeh Su

Dr. Yung-Yeh Su’s Story

Dr. Su is a clinician-scientist dedicated to advancing precision oncology for hepatobiliary and pancreatic cancers through investigator-initiated trials and translational research. His work integrates clinical data with next-generation sequencing to dissect tumor heterogeneity. In pancreatic cancer, he advanced endoscopic biopsy techniques (Gastrointestinal Endoscopy, 2023), enabling landmark single-cell sequencing studies (Molecular Cancer, 2025), and identified key germline and pharmacogenomic markers to personalize therapy (Clin Cancer Res, 2026). In hepatocellular carcinoma, his research has been pivotal in defining immunotherapy response mechanisms, including pathological response criteria (Lancet Oncology, 2024), features of durable benefit (Journal of Clinical Oncology, 2024), and the role of B-cells in treatment efficacy (Journal of Hepatology, 2025).

With over 40 peer-reviewed articles, Dr. Su’s research excellence is recognized by the JSMO Young Investigator Award for four consecutive years (2022–2025) and the 2024 Taiwan Oncology Society Young Investigator Paper Award.

Research Interest

Tumor Heterogeneity, Next-Generation Sequencing & scRNA-seq, Translational Research & Immunotherapy Response, Precision Oncology in GI Cancers

Qualifications, certified physicians, medical specialists, etc.

Board of Medical Oncology

Specialized field

Clinical trials and translational research in hepatobiliary and pancreatic cancers.

Professional Experience

  • Assistant Investigator and Attending Physician, National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan
  • Adjunct Attending physician, Department of Internal Medicine, Kaohsiung Medical University Hospital and Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan
  • Adjunct Attending physician, Department of Oncology, National Cheng Kung University Hospital, Tainan, Taiwan
  • Visiting Scholar, Stanford Cancer Center, California, USA.
  • Fellow, Division of Medical Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan
PAGE TOP